Reduction of opioid side effects by prophylactic measures of palliative care team may result in improved quality of life

Journal of Palliative Medicine

Volumn 13, Issue 4, 2010, Pages 401-406

  Myotoku, Michiaki ^a   Nakanishi, Akiko ^b   Kanematsu, Miwa ^b   Sakaguchi, Noriko ^b   Hashimoto, Norio ^b   Koyama, Fumiko ^b   Yamaguchi, Seiji ^b   Ikeda, Kenji ^a   Konishi, Hiroki ^a   Hirotani, Yoshihiko ^a  

^a OSAKA OHTANI UNIVERSITY   (Japan)

^b Ikeda Municipal Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; FENTANYL; LAXATIVE; MORPHINE; MORPHINE SULFATE; OPIATE; OXYCODONE;

ADULT; AGED; ANOREXIA; ARTICLE; CONSTIPATION; DEFECATION HABIT; DIETARY INTAKE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PALLIATIVE THERAPY; PRESCRIPTION; QUALITY OF LIFE; VOMITING;

AGED; ANALGESICS, OPIOID; ANOREXIA; CONSTIPATION; DRUG TOXICITY; FEMALE; HEALTH CARE SURVEYS; HUMANS; INCIDENCE; INPATIENTS; MALE; NAUSEA; PALLIATIVE CARE; PATIENT CARE TEAM; QUALITY OF LIFE; RISK ASSESSMENT; RISK REDUCTION BEHAVIOR; VOMITING;

EID: 77951826659     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2009.0355     Document Type: Article

References (34)

1. Koido K, Saito K, Sawada D, Hayasaka K, Miyano S, Yoshino K: Morphine ni yoru gan-totsu kanwa, Department of Pharmacy, National Cancer Center Hospital. Tokyo: MIX=Elsevier Science K.K., 2001, pp. 108-170.
2. World Health Organization. Cancer Pain Relief. Geneva: World Health Organization, 1986.
3. Myotoku M, Murayama Y, Nakanishi A, Kawaguchi S: Role of pharmacists in palliative care team: Survey of trend in narcotics dosages before and after establishment of palliative care team. Jpn J Pharm Health Care Sci 2005;31:1012-1018.
4. Myotoku M, Murayama Y, Nakanishi A, Hashimoto N, Koyama F, Irishio K, Kawaguchi S, Yamaguchi S, Ikeda K, Hirotani Y: Assessment of palliative care team activities- Survey of medications prescribed immediately before and at the beginning of opioid usage. Yakugaku Zasshi 2008; 128:299-304.
5. Yamanouchi T, Nagata Y, Kawashiri N, Mimura Y, Kawakami J, Adachi I: Consumption of morphine preparations in Toyama Medical and Pharmaceutical University Hospital. J Pharm Soc Jpn 2004;124:13-18.
6. The Japanese Society for Palliative Medicine. Evidence- Based Medicine-Supported Cancer Pain Management Guideline 1999 Committee. The Japanese Society for Palliative Medicine. Evidence-Based Medicine-Supported Cancer Pain Management Guideline. Tokyo: Shinko Trading Co Ltd. Publication Department, 2000, pp. 68-78, pp. 92-103.
7. Jacox A, Carr DB, Payne R: Management of Cancer Pain. Clinical Practice Guideline. AHCPR Pub. No.94-0592. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Service. 1994, pp. 61-65.
8. Poulain P: Development and research of patient analgesia and continuing care program for ambulatory and home care cancer patients [meeting abstract]. Paris: 7th World Congress on Pain, 1993, pp. 22-27.
9. Ikenaga M: Gansei-totsu ni okeru morphine-seizai siyou no tyuiten. Clin Drug Ther 1996;15:253-255.
10. Mannix KA: Palliation of nausea and vomiting. In: Oxford Textbook of Palliative Medicine, 3rd ed. Oxford: Oxford University Press, 2004, pp. 333-334, pp. 459-468.
11. Tuneto S: New Palliative Medicine [Saishin kanwairyo-gaku]. Osaka: Saishin-igaku Corporation, 1999, pp. 93-102.
12. McNicol E, Horowicz-Mehler N, Fisk RA, Bennett K, Gialeli- Goudas M, Chew PW, Lau J, Carr D: Management of opioid side effects in cancer-related and chronic noncancer pain: A systematic review. J Pain 2003;4:231-256.
13. Twycross R: Oral Morphine, Pain Relief in Advanced Cancer. London: Churchill Livingstone, 1994, pp. 307-332.
14. Mercadante S: Opioid rotation for cancer pain: Rationale and clinical aspects. Cancer 1999;86:1856-1866.
15. Heiskanen T, Kalso E: Controlled-release oxycodone and morphine in cancer related pain. Pain 1997;73:37-45.
16. Bruera E, Belzile M, Pituskin E, Fainsinger R, Darke A, Harsanyi Z, Babul N, Ford I: Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled- release oxycodone with controlled-release morphine in patients with cancer pain. J Clin Oncol 1998;16:3222-3229.
17. Lauretti GR, Oliveira GM, Pereira NL: Comparison of sustained- release morphine with sustained-release oxycodone in advanced cancer patients. Br J Cancer 2003;89:2027-2030.
18. Koido K, Saito K, Sawada D, Hayasaka K, Miyano S, Yoshino K: Morphine ni yoru gan-totsu kanwa, Department of Pharmacy, National Cancer Center Hospital. Tokyo: MIX=Elsevier Science K.K., 2001, pp. 108-170.
19. World Health Organization. Cancer Pain Relief. Geneva: World Health Organization, 1986.
20. Myotoku M, Murayama Y, Nakanishi A, Kawaguchi S: Role of pharmacists in palliative care team: Survey of trend in narcotics dosages before and after establishment of palliative care team. Jpn J Pharm Health Care Sci 2005;31:1012-1018.
21. Myotoku M, Murayama Y, Nakanishi A, Hashimoto N, Koyama F, Irishio K, Kawaguchi S, Yamaguchi S, Ikeda K, Hirotani Y: Assessment of palliative care team activities- Survey of medications prescribed immediately before and at the beginning of opioid usage. Yakugaku Zasshi 2008; 128:299-304.
22. Yamanouchi T, Nagata Y, Kawashiri N, Mimura Y, Kawakami J, Adachi I: Consumption of morphine preparations in Toyama Medical and Pharmaceutical University Hospital. J Pharm Soc Jpn 2004;124:13-18.
23. The Japanese Society for Palliative Medicine. Evidence- Based Medicine-Supported Cancer Pain Management Guideline 1999 Committee. The Japanese Society for Palliative Medicine. Evidence-Based Medicine-Supported Cancer Pain Management Guideline. Tokyo: Shinko Trading Co Ltd. Publication Department, 2000, pp. 68-78, pp. 92-103.
24. Jacox A, Carr DB, Payne R: Management of Cancer Pain. Clinical Practice Guideline. AHCPR Pub. No.94-0592. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Service. 1994, pp. 61-65.
25. Poulain P: Development and research of patient analgesia and continuing care program for ambulatory and home care cancer patients [meeting abstract]. Paris: 7th World Congress on Pain, 1993, pp. 22-27.
26. Ikenaga M: Gansei-totsu ni okeru morphine-seizai siyou no tyuiten. Clin Drug Ther 1996;15:253-255.
27. Mannix KA: Palliation of nausea and vomiting. In: Oxford Textbook of Palliative Medicine, 3rd ed. Oxford: Oxford University Press, 2004, pp. 333-334, pp. 459-468.
28. Tuneto S: New Palliative Medicine [Saishin kanwairyo-gaku]. Osaka: Saishin-igaku Corporation, 1999, pp. 93-102.
29. McNicol E, Horowicz-Mehler N, Fisk RA, Bennett K, Gialeli- Goudas M, Chew PW, Lau J, Carr D: Management of opioid side effects in cancer-related and chronic noncancer pain: A systematic review. J Pain 2003;4:231-256.
30. Twycross R: Oral Morphine, Pain Relief in Advanced Cancer. London: Churchill Livingstone, 1994, pp. 307-332.
31. Mercadante S: Opioid rotation for cancer pain: Rationale and clinical aspects. Cancer 1999;86:1856-1866.
32. Heiskanen T, Kalso E: Controlled-release oxycodone and morphine in cancer related pain. Pain 1997;73:37-45.
33. Bruera E, Belzile M, Pituskin E, Fainsinger R, Darke A, Harsanyi Z, Babul N, Ford I: Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled- release oxycodone with controlled-release morphine in patients with cancer pain. J Clin Oncol 1998;16:3222-3229.
34. Lauretti GR, Oliveira GM, Pereira NL: Comparison of sustained- release morphine with sustained-release oxycodone in advanced cancer patients. Br J Cancer 2003;89:2027-2030.